‌

US Patent 11965163 HNF4a saRNA compositions and methods of use

Patent 11965163 was granted and assigned to MiNA Therapeutics on April, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

1

Patent attributes

Patent Applicant

MiNA Therapeutics

1

Current Assignee

MiNA Therapeutics

1

Patent Jurisdiction

United States Patent and Trademark Office

1

Patent Number

Patent Inventor Names

Markus Hossbach1

Jon Voutila1

David Blakey1

Hans E. Huber1

Monika Krampert1

Date of Patent

April 23, 2024

1

Patent Application Number

174876641

Date Filed

September 28, 2021

1

Patent Citations

US Patent 9944930 Albumin production and cell proliferation

1

US Patent 7452987 Interfering RNA molecules

1

US Patent 7820809 Functional and hyperfunctional siRNA directed against Bcl-2

1

US Patent 9745579 Albumin production and cell proliferation

1

US Patent 10758624 Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereof

1

Patent Primary Examiner

1

Patent abstract

The invention relates to saRNA targeting an HNF4a transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11965163 HNF4a saRNA compositions and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.